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IC50    concentration required inhibiting 50% of effect 
J    coupling constant 
L    liter 
Ȝmax    lambda (maximum wavelength) 
m    multiplet 
MHz    mega hertz 
MIC    minimum inhibitory concentration 
min    minutes 
mL    milliliter 
mol    mole 
MP    melting point 
mp    melting point 
m/z    mass/charge 
ȝg    microgram 
ȝM    micro molar 
ȝg/mL    micro gram per milliliter 
nm    nanometer 
ppm    parts per million 
%    percentage 
s    singlet 
t    triplet 
TB    tuberculosis 
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td    triplet of doublet 
TMS    tetramethylsilane 
v/v    volume/volume 
w/v    weight/volume 
w/w    weight/weight 
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SINTESIS, PENCIRIAN DAN AKTIVITI MIKROBIAL THIAZOL, 
THIAZOLIDINON, THIADIAZOL DAN FENILAKRILOHIDRAZID 
TERCANTUMKAN TERBITAN KUMARIN BARU 
 
ABSTRAK 
 Thiazol, thiazolidinon, thiadiazol, fenilakrilohidrazid dan kumarin merupakan 
sebahagian daripada kelas sebatian heterosiklik yang mempunyai kepentingan dalam 
bidang perubatan dan farmakologi. Dalam kajian ini enam siri daripada 67 sebatian 
kumarin baru yang aktif secara biologi telah disintesis dengan mencantumkan unit 
thiazol, thiazolidinon, thiadiazol dan fenilakrilohidrazid ke dalam rangka kumarin 
untuk meningkatkan kegunaannya sebagai agen terapeutik yang penting. Semua 
terbitan yang telah disintesis dicirikan menggunakan teknik spektroskopik seperti IR, 
1D NMR (1H dan 13C) dan analisis CHN bersama LC-MS. Struktur terbitan terpilih 
telah dipastikan lebih dengan lanjut menggunakan teknik spektroskopik 2D NMR 
(COSY, HMQC dan HMBC). Di samping itu, analisis pembelauan X-Ray telah 
digunakan bagi mengesahkan struktur sebatian yang diperolehi adalah kristal 
tunggal. Struktur semua bahan permulaan yang disintesis telah disahkan dengan 
membandingkan data spektroskopi tersebut dengan yang telah dilaporkan dalam 
literatur. Sukatan takat lebur telah dijalankan kepada semua sebatian bagi memeriksa 
ketulenan mereka. Semua terbitan yang disintesis telah melalui saringan in vitro bagi 
aktiviti antibakteria terhadap dua bakteria jenis Gram-positif Streptococcus 
pneumoniae dan Staphylococcus aureus dan tiga bakteria jenis Gram-negatif 
Escherichia coli, Enterobacter aerogenes dan Salmonella typhi, termasuklah 
Mycobacterium tuberculosis bakteria penyebab penyakit tuberkulosis. Aktiviti 
signifikan terhadap Mycobacterium tuberculosis telah ditunjukkan oleh hampir 
kesemua sebatian. Perencatan terkuat telah ditunjukkan oleh 29g sebatian terhalogen 
xxv 
 
dengan nilai MIC terendah 60.0 ȝM, manakala analognya 29f dan kumarin lain 27b, 
30a dan 26 juga mendedahkan aktiviti yang baik, masing-masing dengan nilai-nilai 
MIC 83, λ3, 83 dan λ3 ȝM berbanding dengan ubat kawalan, Isoniazid. Selain itu, 
dalam aktiviti perencatan anti-bakteria yang paling kuat terhadap strain bakteria yang 
disebutkan di atas diperhatikan lagi menggunakan kumpulan sebatian terhalogen 
(27b, 28b, 28i, 28p, 29d, 29h, 30b, 31b dan 32d), dengan nilai-nilai MIC antara 34 
hingga 233 ȝM berbanding dengan ubat standard streptomycin, kanamycin dan 
vancomycin. Terbitan kumarin lain juga didapati mempamerkan aktiviti-aktiviti anti 
bakteria yang ketara. Keputusan kajian ini menyimpulkan potensi penggunaan 
terbitan kumarin, dalam bidang perubatan dan ubatan. 
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SYNTHESIS, CHARACTERIZATION AND MICROBIAL ACTIVITY 
OF NEW THIAZOLE, THIAZOLIDINONE, THIADIAZOLE AND PHENYL 
ACRYLOHYDRAZIDE SUBSTITUTED COUMARIN DERIVATIVES 
 
ABSTRACT 
 Thiazoles, thiazolidinones, thiadiazoles, phenylacrylohydrazides and 
coumarins, are few of the very important classes of heterocyclic compounds having 
great medicinal and pharmacological importance. In the present study, six series of 
67 new biologically active coumarin derived compounds have been synthesized by 
substituting thiazole, thiazolidinone, thiadiazole and phenylacrylohydrazide units 
into the coumarin core, in order to increase their use as important therapeutic agents. 
The structures of all the new compounds were characterized by spectroscopic 
techniques such as, IR, 1D NMR (1H and 13C) and CHN analysis together with LC-
MS. The structures of the selective compounds from each series were further 
confirmed by 2D NMR (COSY, HMQC and HMBC) spectroscopic techniques. In 
addition to this X-Ray diffraction analysis was used to confirm, the structures for 
those compounds obtained as single crystals. The structures of all the synthesized 
starting materials were confirmed by the comparison of their spectroscopic data with 
those already reported in literature. Melting point measurements was done for all the 
synthesized compounds, in order to check their purity. All the synthesized coumarin 
analogues were screened in vitro for their antibacterial activity against two Gram-
positive bacteria Streptococcus pneumoniae and Staphylococcus aureus and three 
Gram-negative bacteria Escherichia coli, Enterobacter aerogenes and Salmonella 
typhi, including Mycobacterium tuberculosis, a bacterium which causes tuberculosis 
disease. Significant activity against Mycobacterium tuberculosis was shown by 
almost all the compounds. Strongest inhibition was shown by the halogenated 
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compound 29g with the lowest MIC value of 60.0 ȝM, while its analogue 29f and the 
other coumarins 27b, 30a and 26 also revealed good activities with MIC values of 
83, λ3, 83 and λ3 ȝM, respectively as compared to that of the control drug, Isoniazid. 
Moreover, in antibacterial activity the strongest inhibition against the aforementioned 
bacteria strains were observed again by the group of halogenated compounds (27b, 
28b, 28i, 28p, 29d, 29h, 30b, 31b, and 32d), with MIC values ranging from 34 to 
233 ȝM as compared to those of  the standard drugs streptomycin, kanamycin and 
vancomycin. Rest other coumarin derivatives were also found to exhibit significant 
anti bacterial activities. The results of this study concluded the potential uses of 
coumarin derived compounds, in medicine and drug discovery. 
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CHAPTER 1 
INTRODUCTION 

1.1 Coumarin 
 Coumarin and many of its derivatives occur naturally. Coumarins owe their 
class name to ‘Coumarou’ which came from the plant Coumarouna odorate. 
Coumarin was first isolated in 1820 from the fruit of Dipteryx odorata Wild by 
Vogel (Bruneton, 1999). Coumarin is classified as a member of the benzopyrone 
family, which consist of a benzene ring fused with α-pyrone ring (1), known as1,2-
benzopyrone. Benzopyrones can be further subdivided into benzo-α-pyrones, a class 
to which the coumarins belong and benzo-Ȗ-pyrones, a class to which flavonoids are 
the principal members. The systematic name of coumarin is 2H-1-benzopyran-2-one. 
 
 
 
 Coumarin (1)         Substituted 3-acetyl coumarins (2) 
R = Alkyl, alkoxy, halogen or any 
other substituent 
 
 A literature survey revealed that heterocyclic compounds containing 
coumarin shows diverse biological activities such as anticonvulsant (Dimmock et al., 
2000), antioxidant (Osman et al., 2012), anti-HIV (Hariprasad et al., 1998), 
antibacterial (Arshad et al., 2011), anticoagulant (Jain et al., 2012), anti-cancer 
(Federica et al., 2010) and anti-fungal (Singh et al., 2010). Coumarin also has 
paramedicinal applications and it is used in the treatment of psoriasis and other 
dermatological disorders. Therefore, natural, semi-synthetic and synthetic coumarins 
are of immense value in the field of pharmaceutical research. 
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 Coumarin is also widely used as an aroma chemical because of its specific 
odor, stability to alkali and temperature, tenacity and relatively cheap price. It has 
been used as a sweetener and fixative in perfumes, a fragrance enhancer for natural 
essential oils, blender in soaps and detergents, an aroma enhancer in tobacco and for 
imparting pleasant odors to industrial products. Their derivatives are used as 
intermediates for the synthesis of heterocyclic ring systems which are of great 
importance and are associated with a wide spread popularity in the field of medicine. 
 For example, the 3-acetyl coumarin derivatives (2), which were synthesized 
by the reaction of different substituted salicylaldehyde with ethylacetoacetate in the 
presence of piperidine, had been proved to be important. 
1.2. Problem statement 
 Microbial infections are one of the leading causes for the suffering and death 
of human beings, among which tuberculosis is considered to be one of the most life 
threatening disease. It is caused by Mycobacterium tubercule, a very pathogenic 
bacterium. Despite lot of advances made in drug research, TB still remains one of the 
major health problems today. It is estimated that more than 2 billion people are 
infected with TB, thus leading to approximately 6% of all deaths worldwide 
(Lonnorth & Rviglione, 2008). Poverty, HIV and drug resistance are the major 
contributors to the resurging global TB epidemics (Cobert et al., 2006). TB is 
currently the leading killer of youth, women and AIDS patients in the world. 
 The global increase in resistance to antimicrobial drugs, including the 
antibacterial drugs, has also created several public health issues. The resistance 
development is a problem whenever antibacterial drugs are used for the treatment of 
bacterial infections. This is increasing high-risk in the populations who frequently 
require antibacterial therapy. Therefore, a renewed effort to increase awareness for 
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antibacterial drugs is needed in order to slow its development. In recent years, 
antibiotic-resistant microbial infections have become a growing concern. With the 
threat of traditional antibiotics and antimicrobial agents becoming obsolete, the 
development of new classes of antibiotics has become an important subject of current 
research. Naturally occurring defense methods have shown potential as alternatives 
to the currently available antibiotics, but bioavailability complications and the high 
cost of production have limited their translation into the clinics. Hence, there seems 
to be an urgent need for new anti-TB and antibacterial drugs. Arshad et al. (2011) 
recently synthesized a series of anti-TB and antibacterial coumarin derivatives. These 
compounds are potent enough to inhibit TB and bacterial infections. 
 These information prompted us also, to synthesize some new coumarin 
derivatives with possible anti-TB and antibacterial activity. Stability of coumarin in 
aqueous solution and heat resistant nature, make these compounds pharmacologically 
important. 
1.3. Research objectives  
 Preparation of derivatives and evaluation of their activities is an interesting 
topic of research in the field of medicinal chemistry. The word derivative is a term of 
broad definition. It involves different kinds of chemical modifications of an existing 
drug by using different approaches, for preparing various structural combinations. 
Bearing this in mind, we set out to prepare several new series of biologically active 
compounds containing, coumarin, thiazole ring, thiazolidinone ring, thiadiazole ring 
and phenylacrylohydrazide unit within the molecular framework.  
The present work focuses on three main research objectives:  
i. To synthesize six new series of heterocyclic compounds by incorporating 
      thiazole ring, thiazolidine ring, thiadiazole ring and phenylacrylohydrazide 
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     moiety into coumarin core. 
ii. To characterize all the synthesized compounds by different spectroscopic 
     techniques (IR, 1D & 2D NMR, LC-MS), CHN elemental analysis and to   
     determine and confirm the exact configuration of some derivatives by X-ray 
crystallography. 
iii. To evaluate the antibacterial and anti-tuberculosis activities of the 
synthesized compounds against Gram-positive (S. aureus and S. 
Pneumonia) and Gram-negative (E. coli, S. typhi and A. aerogenes) 
bacterial strains and Mycobacterium tuberculosis, respectively. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1. Classification of coumarin 
 Gottlieb et al. (1978) used a biogenetic way which was based on the presence 
of number of nuclear oxygen atoms for the classification of coumarins. Many natural 
coumarins have also been classified by botanically derived names, mostly ending 
with the suffixes, “–ol” or “–one”. Kennedy & Lacy., (2004) on the other hand, 
classified coumarin into four subgroups. By virtue of its structural simplicity 
coumarin has been assigned as the representative member of the benzo-α-pyrones 
(Table 1.1). 
Table 1.1: The four main coumarin subtypes. The main structural features and examples of each  
     coumarin subtypes. 
 
Classification Features Examples 
Simple coumarins Hydroxylated, 
alkoxylated or 
alkylated on benzene 
ring 
 
7-hydroxycoumarin (3) 
Furanocoumarins 5-membered furan 
ring attached to 
benzene ring. Linear 
or Angular 
 
   Psoralen (4)               Angelicin (5)       
Pyranocoumarins 6-membered pyran 
ring attached to 
benzene ring. Linear 
or Angular 
 
Seselin (6)                  Xanthyletin (7) 
Pyrone-substituted 
coumarins 
Substitution on 
pyrone ring, often at 
3-C or 4-C positions 
 
Warfarin (8) 
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2.2. Biological activities of coumarin and its derivatives
 
 Coumarins belong to a biologically active class of compounds as they show 
quite diverse biological activities. They have  been reported to be wonder compounds 
possessing anticoagulant, antiallergic, vascodilatory, anthelmintic, diuretic, 
insecticidal, anticancer, antioxidant, anti tuberculosis, antimicrobial, anticonvulsant, 
analgesic, anti-inflammatory, antitumor and antibiotic activities. Coumarin 
derivatives are important pharmacological compounds and precursors in medicinal 
drug synthesis such as sulfathiazole, an antibiotic. These activities make coumarin 
compounds, attractive backbone derivatives for screening as new therapeutic agents. 
2.2.1. Antibacterial activity of coumarin derivatives 
 During the past two decades, the developed immunity in the growing 
population of patients, with malignancies and transplant recipients, has resulted in an 
increase in severe opportunistic microbial infections. Therefore, the health problems 
arising, demands urgency, to develop new authentically genuine, low-toxic 
antimicrobial drugs, which can overcome the current medications.  
 Therefore, in an attempt to find new agents to fight against bacterial 
infections, Singh et al., (2010) reported two series of coumarin based antibacterial 
compounds.They synthesized 3-[(2'-substituted benzylidene amino thiazol-4'-yl) 
amino] coumarins (9a-d) and 3-[(2'-substituted benzylidine amino oxazole-4'-yl) 
amino coumarins (10a-d). All the synthesized compounds were screened for their in 
vitro antibacterial activities. The results showed, that compound 9d and 10d, with 
para methoxy substituent had good antibacterial activity as compared to their 
homologues 9a-c and 10a-c.  
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9a-d:  X= S 
10a-d:  X= O 
 
Compound R Compound R 
9a H 10a H 
9b p-OH, m-OCH3 10b p-OH, m-OCH3 
9c o-OH 10c o-OH 
9d p-OCH3 10d p-OCH3 
 
 Kamal et al. (2010) had synthesized a new series of cyclodextrin linked 
coumarins (11a-g) and evaluated their antimicrobial activities. All the compounds 
showed significant antimicrobial activities against Gram-positive viz. Staphylococcus 
aureus and Staphylococcus epidermidis and Gram-negative viz. Escherichia coli and 
Pseudomonas aeruginosa bacterial strains. The compounds exhibited up to four fold 
improved biological activities as compared to their precursors. 
 
 
 
11a-g 
 
Compound R1 R2 R3 
11a H H H 
11b OCH3 H H 
11c H Cl H 
11d H CHCH2CH2CH CHCH2CH2CH 
11e Cl Cl H 
11f H Br H 
11g Br Br H 
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 In addition to these, hydrazinyl thiazolyl coumarin derivatives (12a-d) were 
tested in vitro by Arshad et al., (2011) against different bacteria. Compound 12a, 
having a hydroxyl group at ortho position, exhibited significant antibacterial activity. 
 
 
 
12a-d 
Compound R1 R2 R3 R4 
12a OH H H H 
12b H OH H H 
12c H H OH H 
12d OH H OH H 
 
 Moreover, very recently Parmar et al., (2013) tested the in vitro antibacterial 
activities of a new series of 2-(4-methyl-7-hydroxy-coumarin)-4-(cyclohexylamino)-
6-(arylamino)-s-triazine coumarin derivatives (13a-j). All the compounds showed 
significant antibacterial activities against Gram-positive viz. Staphylococcus aureus 
and Bacillus subtilis and Gram-negative viz. Escherichia coli and Pseudomonas 
aeruginosa bacterial strains. 
 
13a-j 
Compound R Compound R 
13a p-toludine 13f p-chloroaniline 
13b p-fluoroaniline 13g m-toluidine 
13c 3-chloro-4-fluoroaniline 13h (4-aminophenyl)(methyl) amide 
13d p-nitroaniline 13i m-chloroaniline 
13e p-methoxyaniline 13j m-bromoaniline 
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 Kasumbwe et al. (2014) had reported in vitro antibacterial activities of 
coumarin based halogen compounds (14a-f). The result showed that compounds 14c 
and 14f exhibited very good antibacterial activities with MIC value of 0.75 mg/mL 
as compared to its analogues. 
 
 
14a-f 
Compound R R1 R2 Compound R R1 R2 
14a Br H H 14d Cl Br H 
14b Cl H H 14e Br Br H 
14c H Br H 14f H Br Br 
   
 Patel et al. (2014) had synthesized two new series of coumarin-based 
oxadiazoles (15a-k; 15-v) and evaluated their in vitro antibacterial potential against 
several bacteria. There studies was based on structural relationship which showed, 
that up to what extent the presence of various electron withdrawing or electron 
donating groups, which were present on phenyl or benzothiazole ring system, can 
affect the activity profiles of the newer molecules. From the results it was concluded, 
that almost all the coumarin derivatives were found to show good MIC values 
ranging in between 6.25-100 g/mL. However, exceptionally good activities were 
shown by the analogues, with electron donating groups such as halogen, methoxy 
and cyano substituents, present on phenyl or benzothiazole ring. Whereas, 
compounds with electron withdrawing groups such as the nitro group (15f, 15q), 
were found to show comparatively higher MIC values. 
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                                                  15a-k                                                 15l-v 
 
Compound R Compound R 
15a;15l H 15g;15r CN 
15b;15m Cl 15h;15s CH3 
15c;15n Br 15i;15t OCH3 
15d;15o F 15j;15u OC2H5 
15e;15p I 15k;15v NHCOCH3 
15f;15q NO2 - - 
 
2.2.2. Anti-tuberculosis activity of coumarin derivatives 
 Mycobacterium tuberculosis, which is responsible for most of the 
tuberculosis cases, is one of the most pathogenic bacterial strains ever reported. 
Tuberculosis has now become more severe, due to the resistance developed by 
Mycobacterium tuberculosis, against the first line as well as second line drugs. 
Multidrug-resistant TB cases which were reported in 2010, were in their highest level 
(Koul et al., 2011). In Malaysia, TB claimed some, 1,700 lives and infected 19,250 
people in 2011 (WHO, 2011). Almost 90 % of the TB cases were patients with 
known HIV status, because activation of TB occurs when the person’s immune 
system is somehow impaired, either by age, malnutrition, or by other diseases such 
as acquired immune-deficiency syndrome (AIDS). The cause of death due to TB was 
largely due to its late detection. Hence, there is urgent need to develop new 
molecules against this deadly pathogen. Coumarin and its derivatives have gained 
great therapeutic importance in the field of medicinal chemistry, as they display a 
fascinating array of pharmacological properties.  
In this regard Bhila et al., (2013) had studied the anti-tuberculosis activities of 
pyridyl coumarin derivatives (16a-l), against Mycobacterium tuberculosis H37Rv. 
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The results showed that all the coumarin compounds exhibited very good MIC 
values ranging in between 62.5-1000 g/mL. 
 
 
16a-l 
Compound R1 R2 R3 R4 Compound R1 R2 R3 R4 
16a H H H H 16g H Br H H 
16b H H H CH3 16h H Br H CH3 
16c H H H Cl 16i H Br H Cl 
16d OCH3 H H H 16j H benzo H H 
16e OCH3 H H CH3 16k H benzo H CH3 
16f OCH3 H H Cl 16l H benzo H Cl 
 
 More studies were conducted by Arshad et al., (2011) on thiazole coumarin 
derivatives. All the derivatives (17a-d), were screened in vitro against 
Mycobacterium tuberculosis. Compounds 17c and 17d exhibited very good activities 
with the MIC values17 and 15 M, as compared to the standard drug Isoniazid. 
 
 
 
17a-d 
Compound R 
17a 4-(1-iminoethyl)phenol 
17b diphenylmethanimine 
17c 7-hydroxy-3(1-iminoethyl)-2H-chromen-2one 
17d 6-bromo-3-(1-iminoethyl)-2H-chromen-2one 
 
 Very recently, Ambre et al., (2014) had synthesized a set of 16 coumarin 
based pyrimidine derivatives (18a-p) with anti-tubercular potential. They recorded 
the % inhibition of all the compounds at concentration level of 128 M. The results 
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showed that the presence of electron donating groups like methyl, methoxy and 
hydroxyl on the phenyl ring system imparted greater anti-tubercular activity. 
 
 
 
X=S; 18a-h 
X=O; 18i-p 
 
Compound R R1 
18a;18i H H 
18b;15j H 4-OCH3 
18c;15k H 3,4-OCH3 
18d;18l CH3 4-OCH3 
18e;18m CH3 3,4-OCH3 
18f;18n H 3-OCH3;4-OH 
18g;18o H 3-Br 
18h;18p H 3-Br 
 
 Moreover, Angelova et al., (2014) had synthesized eight coumarin-derived 
aminoalcohols and amidoamines (19a-h) and evaluated their in vitro anti-
tuberculosis activity against Mycobacterium tuberculosis H37Rv. Ethambutol was 
used as the standard drug. All of the tested compounds displayed, 10-20 times higher 
activities, ranging in between 0.32-19.2 M as compared to the standard drug, which 
was found to display the MIC value of 7.22 M. 
 
 
19a-h 
Compound R1 R2 
19a NH(CH2)2OH H 
19b NHCH2CH(OH)CH3 H 
19c NH(CH2)2NHCOCH3 H 
19d NH(CH2)3NHCOCH3 H 
19e NH(CH2)2OH N(CH2)2OH 
19f NH(CH2)3OH N(CH2)3OH 
19g NHCH2CH(OH)CH3 CHO 
19h C=O N(CH2)2OH 
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 In addition to this, Stanley at al., (2013) had synthesized, a very important 
diaryl coumarin derivatives series (20a-d), which kills Mycobacterium tuberculosis, 
by inhibiting fatty acid degradation protein D32 (FadD32). Fad32 is an essential 
enzyme which is required in the biosynthesis of mycolic acids. Mycolic acid is an 
important component of a typical mycobacterium cell-wall. These substituted 
coumarin inhibitors directly inhibit the acyl-acyl carrier protein synthetase activity of 
FadD32. As a result, they effectively block bacterial replication both in vitro and in 
vivo, in the same pathway as the established antibiotic Isoniazid. 
 
 
20a-d 
Compound R1 R2 
20a pyridine H 
20b phenyl methanol H 
20c 4-benzylmorphine H 
20d 4-benzylmorphine NH2 
 
2.3. Synthesis of coumarin derivatives 
 Methods to synthesize coumarin derivatives have been well developed. 
Among which are, the Pechmann, Claisen, Perkin, Knoevenagel, Reformatsky, 
Hantzch and Wittig reactions. 
2.3.1. Thiazolyl coumarins 
 Thiazole or 1,3-thiazole is a five membered heterocyclic compound which 
contains nitrogen and sulphur atoms. The thiazole ring is planar and aromatic. 
Compounds containing thiazole ring had been reported to possess remarkable 
medicinal values such as antimicrobial (Singh et al., 2010), anti-oxidant (Osman et 
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al., 2012), anti-tuberculosis (Arshad et al., 2011) and anti-cancer (Belluti et al., 2010) 
properties. 
 
 
 
Thiazole         Thiazole-2-imine 
 
 Literature survey revealed that there are several methods to introduce thiazole 
ring to a coumarin nucleus. The most common method to synthesize thiazole is via 
Hantzch reaction, which was first discovered in 1887 by a German chemist, Hantzch. 
This reaction involves condensation of a compound bearing two hetero atoms on the 
same carbon atom (Scheme1.1) such as thioamide, thiourea, thiosemicarbazide, 
ammonium thiocarbamate, dithiocarbamate and their derivatives and a carbonyl 
compound with a halogen atom on the alpha carbon next to carbonyl group (Joule et 
al., 1995). 
 
 
R1/R2 = Alkyl, aryl or any other substituent 
Scheme 1.1: Thiazole synthesis via Hantzch reaction 
 
 In the present study, Hantzsch cyclization was used to incorporate the 
thiazole ring into the coumarin nucleus as shown in Scheme 1.1. This method has 
several advantages as it allows alkyl, aryl or heterocyclic substituent to be placed in 
any position of the 5-membered ring. It involves simple work-up and usually a single 
product is obtained. 
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2.3.2. Thiazolidinone coumarins 
 Thiazolidine is a class of heterocyclic organic compounds with a 5-
membered saturated ring with a thioether group and an amine group in 1 and 3 
positions, respectively. Thiazolidine-4-one or thiazolidinone is one of its substituted 
forms. Compounds containing thiazolidinone ring had been reported to possess 
remarkable medicinal values such as antimicrobial (Lobo et al., 2012), anti-
inflammatory (Rekha et al., 2011) and anticonvulsant (Amin et al., 2008).  
 
 
 
     Thiazolidine        Thiazolidin-4-one 
 
 Thiazolidinone can be synthesized in several ways. For example, it can be 
synthesized in very good yield via the acetylation of thiosemicarbazone with sodium 
acetate and chloroacetic acid, in ethanol under reflux, following HSAB principle 
(Hard and soft acid and base) (Bouzroura et al., 2010) (Scheme 1.2). 
 
 
Scheme 1.2: Thiazolidinone synthesis via acetylation of thiosemicarbazone, using chloroacetic acid  
and sodium acetate  
 
In the present work thiazolidinone ring system is introduced to the coumarin 
skeleton, accordingly to the method reported by Bouzroura et al., (2010) (Scheme 
1.2). This method has its own importance as it allows alkyl, aryl or heterocyclic 
substituent to be placed in the third position of the 5-membered ring. It involves 
simple work-up and usually a single product is obtained. 
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2.3.3. Thiadiazole coumarins 
Thiadiazole is a five-membered heterocyclic compound having one sulphur 
and two nitrogen atoms. There are several isomers of thiadiazole, namely 1,2,3-
thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole and 1,3,4-thiadiazole. Compounds 
containing thiadiazole ring had been reported to possess remarkable medicinal values 
such as antimicrobial, antitumor, anti-tuberculosis and cytotoxic properties (El-
Goharya et al., 2013). 
 
 
 
   1,2,3-thiadiazole  1,2,4-thiadiazole   1,2,5-thiadiazole   1,3,4-thiadiazole 
 
 A very convenient method to synthesize thiadiazole is via acetylation of 
thiosemicarbazone with acetic anhydride (Scheme 1.3), following HSAB principle. 
It is a cyclization reaction which involves addition of a mercapto group (thiol group 
or sufanyl group/SH) across CH=N bond and simultaneous acetylation of the NH 
group in the ring and NH2 group in the side chain, thus resulting in the formation of 
1,3,4-thiadiazole (Elokhina et al., 2002 &Mustafa et al., 2008). 
 
 
R’ = H, CH3 
Scheme1.3: Thiadiazole synthesis via acetylation and cyclization of thiosemicarbazone, using  
acetic anhydride 
 
 In the present work, the previously described method was used to introduce 
the thiadiazole ring to the coumarin core (Scheme 1.3). This reaction has advantage 
as the output is a single product, which can be purified by simple recrystallization. 
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2.3.4. Cyanoacetohydrazide coumarins 
 Cyanoacetohydrazide is a versatile intermediate in the synthesis of a variety 
of heterocyclic compounds and its behavior and mechanism of attack is similar to 
that of thiosemicarbazide. The ȕ-functional nitrile moiety of this molecule is a 
favorable unit. Cycloaddition of this unit with numerous reagents will give different 
heterocyclic compounds of various ring sizes, with one or several heteroatoms. 
Cyanoacetohydrazide and its derivatives were known to possess versatile biological 
values and used as pharmaceutical ingredients (Elnagdi et al., 1991 and Gilman et al., 
1985), herbicides (Cosales et al., 1998), antibacterial agents (Marinis et al., 1975)  
and dyes (Fahmy et al., 1980 & Fahmy et al., 1982). Cyanoacetohydrazide coumarins 
are compound in which the cyanoacetohydrazide is attached to the coumarin 
molecule at the position bearing the carbonyl group and hence, it is also known as 
coumarin cyanohydrazone.  
 
  
 
Cyanoacetohydrazide              Cyanoacetohydrazide coumarin 
                                                or Coumarin cyanohydrazone 
 
 An efficient way to synthesize cyanohydrazone derivative in good yield is via 
the reaction of cyanoacetohydrazide and ketone in methanol, in the presence of 
hydrochloric acid, in an ice bath (Scheme 1.4). Coumarin cyanohydrazone is a 
schiff’s base synthesis, as they are synthesized by the reaction between an amine and 
carbonyl compound. This method has been adopted in the present study, in order to 
incorporate the cyanoacetohydrazide moiety into the coumarin core. The reaction is 
very similar to the preparation of simple thiosemicarbazones. The precipitate 
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obtained via this reaction is filtered, washed by ethanol and recrystallized from 
methanol (Doss et al., 2001). 
 
R/X= Alkyl, aryl or any other substituent 
Scheme 1.4: Cyanohydrazone synthesis via Schiff”s base synthesis, using cyanoacetohydrazide  
and ketone 
                        
 In the present work, the previously described method was used to introduce 
the cyanoacetohydrazide unit to the coumarin core (Scheme 1.4). The advantage of 
this method is, single product in good yield. 
2.3.5. 2-Cyano-3-phenylacrylohydrazide coumarins 
 2-Cyano-3-phenylacrylohydrazide coumarins are compounds in which one of 
the methylene protons of cyanohydrazone is replaced by aromatic aldehydes via 
elimination of a water molecule. 2-Cyano-3-phenylacrylohydrazide derivatives are 
very important pharmacological group of compounds possessing antimicrobial 
(Mohareb et al., 2007), antifungal (Mohareb et al., 2007), antitumor (Mohareb et al., 
2010) and many other important medicinal properties. 
 
 
2-Cyano-3-phenylacrylohydrazide coumarin 
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 An efficient way to synthesize 2-cyano-3-phenylacrylohydrazide compounds 
is by Claisen Schmidt condensation reaction. The reaction involves condensation of 
aldehyde or ketone, with the carbonyl compounds lacking an alpha hydrogen, in the 
presence of acid or base as a catalyst. After the reaction completes, the reaction 
mixture is poured in ice cold water, containing few drops of HCl (Mohareb et al., 
2010). The solid product thus obtained, is collected and recrystallized to afford pure 
2-cyano-3-phenylacrylohydrazide compounds (Scheme 1.5). 
 
 
                                                    R1/R2 = Cl, Br, NO2 or any other substituent 
Scheme1.5: 2-Cyano-3-phenylacrylohydrazide derivative synthesis via Claisen Schmidt condensation 
reaction between aromatic aldehydes and cyanoacetohydrazide derivative. 
 
In the present study, 2-cyano-3-phenylacrylohydrazide coumarin was 
synthesized according to the method reported by Mohareb et al., (2010) (Scheme 
1.5). This reaction has advantage as it involves simple work-up and usually a single 
product is obtained. 
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1. Chemicals and solvents 
 The commercial chemicals and reagents used in the syntheses were either of 
analytical reagent grade, laboratory reagent grade or HPLC grade. All solvents were 
used without further purification, unless otherwise stated (Table 3.1). 
Table 3.1: Chemicals, reagents and solvents. 
 
Chemicals, Reagents, Solvents Grade 
Acetic acid glacial AR grade, QRëC, Malaysia 
Acetone AR grade, QRëC, Malaysia 
Ammonium hydroxide, 28-30% NH3 AR grade, Sigma-Aldrich, 
USA Acetic anhydride Sigma-Aldrich, USA 
Bromine Merck, Germany 
Benzaldehyde Acros Organics, Belgium 
5-Bromo-2-hydroxybenzaldehyde Acros Organics, Belgium 
4-Bromobenzaldehyde Acros Organics, Belgium 
2-Bromoacetophenone(phenacyl bromide) AR grade, Sigma-Aldrich, 
USA 2-Bromophenyl thiourea AR grade, Sigma-Aldrich, 
USA Calcium chloride, anhydrous, granular R & M Chemical Essex, UK 
4-Chlorobenzaldehyde Acros Organics, Belgium 
Chloroform AR grade, QRëC, Malaysia 
Chloro acetic acid Sigma-Aldrich, USA 
Cyano acetic acid hydrazide Sigma-Aldrich, USA 
Dichloromethane  AR grade, QRëC, Malaysia 
Diethyl ether AR grade, QRëC, Malaysia 
Dimethyl sulfoxide-d6 99.8 atom % D Sigma-Aldrich, USA 
Dioxane AR grade, QRëC, Malaysia 
2,4-Dihydroxybenzaldehyde Acros Organics, Belgium 
3,4-Dichlorophenyl thiourea Sigma-Aldrich, USA 
Ethanol, 99.7% AR grade, QRëC, Malaysia 
Ethyl acetate AR grade, Fisher Scientific, 
UK Ether AR grade, QRëC, Malaysia 
Ethyl acetoacetate Sigma-Aldrich, USA 
2-Hydroxybenzaldehyde Acros Organics, Belgium 
2-Hydroxy-4-methoxy benzaldehyde Sigma-Aldrich, USA 
2-Hydroxy-5-methoxy benzaldehyde Sigma-Aldrich, USA 
2-Hydroxy-6-methoxy benzaldehyde Sigma-Aldrich, USA 
2-Hydroxy-5-nitro benzaldehyde Sigma-Aldrich, USA 
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4-Hydroxybenzaldehyde Acros Organics, Belgium 
Hydrochloric acid R & M Chemical Essex, UK 
Methanol AR grade, QRëC, Malaysia 
2-Methoxyphenyl thiourea Sigma-Aldrich, USA 
4-Methoxyphenacyl bromide Sigma-Aldrich, USA 
4-Methylphenacyl bromide Sigma-Aldrich, USA 
Molecular sieves type 4A, beads Fluka, Switzerland 
N-Ethyl thiourea Sigma-Aldrich, USA 
N-Methyl thiourea Sigma-Aldrich, USA 
N,N–Diethyl thiourea Sigma-Aldrich, USA 
N,N–Dimethyl thiourea Sigma-Aldrich, USA 
N,N–Diphenyl thiourea Sigma-Aldrich, USA 
Piperidine  BDH, England 
Potassium bromide, FT-IR grade Sigma-Aldrich, USA 
Salicylaldehyde Sigma-Aldrich, USA 
Sodium acetate anhydrous Systerm, Malaysia 
TLC silica gel 60 F254, aluminium sheets, 
20cm x 20cm 
Merck, Germany 
Thiosemicarbazide, 99% Sigma-Aldrich, USA 
 
3.1.1. Preparation of ethanol free chloroform 
 Ethanol free chloroform was prepared by adding concentrated sulphuric acid 
to chloroform and the solution was gently shaken in a separating funnel. The acid 
layer was discarded and chloroform was washed with distilled water, until the 
washing becomes neutral in pH. The chloroform was then dried overnight, over 
anhydrous calcium chloride and distilled the following day. Chloroform purified with 
this method contains less than 0.001% (w/w) of ethanol (Williamson et al., 1995). 
3.1.2. Preparation of dry ethanol 
 Dry ethanol, was prepared according to the method reported by Armarego & 
Chai, (2009) with slight modifications. Ethanol was dried by refluxing it in 
anhydrous calcium oxide (250 gm/L) for 6 hours. The mixture was then allowed to 
stand overnight and filtered the following day. 
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3.1.3. Reaction monitoring 
 The progress of all reactions was monitored by thin layer chromatography 
(TLC). The reaction mixture and the starting materials were both spotted on TLC 
plates, using different solvent systems like petroleum:ether and 
petroleum:ethylacetate. The appearance and disappearance of product and reactant 
spots respectively on TLC, determined the optimum reaction completion time for all 
the reactions. Spots developed on the TLC plates were visualised under UV lamp 
either at 254 and 365 nm of wavelength and in some cases using an iodine chamber. 
3.1.4. Moisture-sensitive reactions  
 All moisture sensitive reactions were performed at normal atmospheric 
pressure in ice bath between 0-5oC. A calcium chloride guard tube was always 
affixed to the reaction flask in order to absorb any moisture during the reactions. All 
glassware used in the reactions were dried overnight in an oven at 120oC. Solvents 
used for the reactions were distilled and dried before use. 
3.1.5. Recrystallization 
 All crude products were purified by recrystallization. Single-solvent and 
multi-solvent systems were used for the purification of crude products. The crude 
products were dissolved in hot condition either in a single solvent or mixture of 
solvents depending upon their solubility. Usually a solvent which dissolves the crude 
products sparingly at room temperature is suitable for recrystallization in hot 
condition. The hot clear solution of the crude product was filtered and concentrated 
by heating to half of its original volume and then allowed to cool slowly at room 
temperature as the slow cooling process gave bigger crystals. The crystals obtained 
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were filtered by suction using a Hirsch funnel and washed with suitable solvents like 
ether or ethanol. 
3.1.6. Melting point measurement 
 Melting points of all the synthesized compounds were determined by Stuart 
Scientific SMP-1 (UK) melting point apparatus in a temperature range of 25–350 °C. 
3.2. Characterization of compounds  
 All the synthesized compounds were characterized by different spectroscopic 
techniques including Infrared (IR) and 1D Nuclear Magnetic Resonance (NMR) 
spectroscopy. However, new derivatives were additionally characterized by LC-MS, 
2D Nuclear Magnetic Resonance (NMR) spectroscopy, elemental analysis (CHN) 
and X-Ray Crystallography techniques. All the spectroscopic analyses and MP 
measurements were carried out at the School of Chemical Sciences, USM whereas 
the X-Ray Crystallographic analysis was conducted at the School of Physics, USM. 
3.2.1. Liquid Chromatography Mass Spectrometry (LC-MS)  
 The molecular mass of the synthesized compounds was determined by LC-
MS. All the measurements were conducted on an Agilent Technologies 6224 TOF 
LC/MS spectrometer at the Department of Chemistry, USM. Agilent Mass Hunter 
software was used to process all the spectra obtained. Samples were prepared as 
solutions of 0.1 to 1.0 g/mL in HPLC grade acetonitrile. The measurements were 
carried out in the positive mode. 
3.2.2. Infrared (IR) Spectroscopy 
 IR spectra of all the synthesized compounds were recorded on Perkin-Elmer 
System 2000 FT-IR spectrometer (England, UK). The samples were prepared as 
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potassium bromide (KBr) discs and scanned in the measurement range of 400- 4000 
cm-1. All the data was analysed by Perkin-Elmer software. 
3.2.3. Nuclear Magnetic Resonance Spectroscopy (NMR) 
 Nuclear magnetic resonance spectra of all the synthesized compounds were 
recorded on a Bruker Avance 500 spectrometer operated at 500 MHz for 1H NMR 
and 125 MHz for 13C NMR, respectively. The 2D spectra (COSY, HMQC and 
HMBC) of the new compounds were recorded on a Bruker Avance 500 spectrometer. 
The spectra were recorded in deuterated solvents (chloroform-d1 or dimethyl 
sulfoxide-d6) containing tetramethylsilane (TMS) as the internal standard. Chemical 
shifts δ, were measured with reference to the TMS signal at 0.00 ppm and the 
coupling constants J, were reported in hertz (Hz). 
3.2.4. Elemental Analysis 
 Elemental analyses for all the synthesized new compounds were performed 
on a Perkin Elmer series II, 2400 CHN analyzer. 
3.2.5. X-Ray Crystallography Analysis  
 Single crystal X-ray crystallographic data analysis was performed on a 
Bruker SMART APEXII CCD area-detector diffractometer and the crystallographic 
structures were solved and refined by using SHELXTL and MERCURY software. 
 
 
 
 
